Chimerix (NASDAQ:CMRX) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Chimerix (NASDAQ:CMRX – Free Report) in a research report released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on CMRX. HC Wainwright reiterated a “neutral” rating and issued a $8.55 price target (down from $11.00) on […]
StockNews.com started coverage on shares of Chimerix (NASDAQ:CMRX – Free Report) in a research report released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on CMRX. HC Wainwright reiterated a “neutral” rating and issued a $8.55 price target (down from $11.00) on […]
